INS and polycystic ovary syndrome: Increased insulin sensitivity and glucoregulation, in turn, may lower androgen synthesis and hyperandrogenemia in women with PCOS, potentially halting the disease process (premature follicle growth arrest) and menstrual irregularity [24].